Nanox (NASDAQ: NNOX) is positioning itself as an integrated medical imaging and healthcare technology company, combining proprietary digital X-ray hardware, FDA-cleared AI applications, cloud software, teleradiology, and healthcare IT into an end-to-end platform designed to support earlier disease detection and more efficient care. Its ecosystem includes Nanox.ARC and the next-generation Nanox.ARC X imaging systems, Nanox.AI algorithms for identifying potential signs of chronic disease, Nanox.CLOUD for imaging management, and services through USARAD, Nanox.MARKETPLACE and Nanox Health IT. The company is expanding commercial and clinical activity through relationships with organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s Hospital, while also licensing its proprietary X-ray technology to equipment manufacturers. Nanox reported first-quarter 2026 revenue of $4.3 million, up from $2.8 million a year earlier, reflecting contributions across imaging, AI, software, teleradiology and healthcare IT, making the company one to watch as it seeks to broaden access to medical imaging and preventive healthcare.
To view the full article, visit https://nnw.fm/42s4r
NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at https://nnw.fm/NNOX
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer